论文部分内容阅读
LAK 细胞(淋巴因子激活的杀伤细胞)具有抗肿瘤抗转移作用。可以杀伤 NK 细胞抵抗的多种自体和同种、新鲜和传代的瘤细胞,而不杀伤正常细胞,因此它没有抑制造血和免疫的副作用。可以用它治疗多种肿瘤,是过继性肿瘤免疫治疗的一个新的有效方法。我们于1991年1月—1994年6月应用
LAK cells (lymphokine activated killer cells) have anti-tumor and anti-metastatic effects. Many autologous and syngeneic, fresh and passaged neoplastic cells can be killed by NK cells without killing normal cells, so it does not inhibit hematopoietic and immune side effects. It can be used to treat a variety of tumors and is a new and effective method for the immunotherapy of adoptive tumors. We applied from January 1991 to June 1994